ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALS

Author:

Cui Lu1,James Hung H. M.2,Wang Sue Jane2,Tsong Yi2

Affiliation:

1. a Department of Biostatistics and Data Management , Aventis Pharmaceuticals, Inc. , Mail Stop BX2-400C, Bridgewater, NJ, 08807, U.S.A.

2. b Office of Biostatistics, OPass, CDER, Food and Drug Administration , Room 15B45, 5600 Fishers Lane, Rockville, MD, 20857, U.S.A.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bayesian shrinkage estimation of credible subgroups for count data with excess zeros;Statistics in Biopharmaceutical Research;2024-08-05

2. Better us later than me now —;Journal of Behavioral and Experimental Economics;2024-02

3. What Do RCTs Tell Us, and Could They Tell Us More? Looking Within and Beyond the Study Sample;A Medical Educator's Guide to Thinking Critically about Randomised Controlled Trials: Deconstructing the "Gold Standard";2024

4. Best practices to promote rigor and reproducibility in the era of sex-inclusive research;eLife;2023-11-02

5. Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials;JACC: Asia;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3